BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23454598)

  • 1. Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis.
    De Freitas Caires N; Legendre B; Parmentier E; Scherpereel A; Tsicopoulos A; Mathieu D; Lassalle P
    J Pharm Biomed Anal; 2013 May; 78-79():45-51. PubMed ID: 23454598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.
    Gaudet A; Parmentier E; Dubucquoi S; Poissy J; Duburcq T; Lassalle P; De Freitas Caires N; Mathieu D
    J Crit Care; 2018 Oct; 47():121-126. PubMed ID: 29957509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocan measurement for the postmortem diagnosis of sepsis.
    Palmiere C; Augsburger M
    Leg Med (Tokyo); 2014 Jan; 16(1):1-7. PubMed ID: 24262651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocan, a new endothelial marker in human sepsis.
    Scherpereel A; Depontieu F; Grigoriu B; Cavestri B; Tsicopoulos A; Gentina T; Jourdain M; Pugin J; Tonnel AB; Lassalle P
    Crit Care Med; 2006 Feb; 34(2):532-7. PubMed ID: 16424738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan elicits severe vascular inflammatory responses in vitro and in vivo.
    Lee W; Ku SK; Kim SW; Bae JS
    J Cell Physiol; 2014 May; 229(5):620-30. PubMed ID: 24446198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients.
    Palud A; Parmentier-Decrucq E; Pastre J; De Freitas Caires N; Lassalle P; Mathieu D
    Cytokine; 2015 Jun; 73(2):213-8. PubMed ID: 25794660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
    Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
    Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
    Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
    J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan is a stable circulating molecule in ICU patients.
    Gaudet A; Chenevier-Gobeaux C; Parmentier E; Delobel JE; Dubucquoi S; Mathieu D; Lassalle P; De Freitas Caires N
    Clin Biochem; 2017 Oct; 50(15):870-877. PubMed ID: 28427918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration and value of endocan on outcome in adult patients after severe sepsis.
    Hsiao SY; Kung CT; Tsai NW; Su CM; Huang CC; Lai YR; Wang HC; Cheng BC; Su YJ; Lin WC; Chiang YF; Lu CH
    Clin Chim Acta; 2018 Aug; 483():275-280. PubMed ID: 29750963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism.
    Güzel A; Duran L; Köksal N; Torun AC; Alaçam H; Ekiz BC; Murat N
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):272-6. PubMed ID: 24509328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic Malignancy.
    Zafrani L; Resche-Rigon M; De Freitas Caires N; Gaudet A; Mathieu D; Parmentier-Decrucq E; Lemiale V; Mokart D; Pène F; Kouatchet A; Mayaux J; Vincent F; N'yunga M; Bruneel F; Rabbat A; Lebert C; Perez P; Meert AP; Benoit D; Darmon M; Azoulay E
    Crit Care Med; 2018 Mar; 46(3):e250-e257. PubMed ID: 29474336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan.
    Smart L; Bosio E; Macdonald SPJ; Dull R; Fatovich DM; Neil C; Arendts G
    J Crit Care; 2018 Oct; 47():93-98. PubMed ID: 29936329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
    Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
    Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
    Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
    Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
    Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.
    Roudnicky F; Poyet C; Wild P; Krampitz S; Negrini F; Huggenberger R; Rogler A; Stöhr R; Hartmann A; Provenzano M; Otto VI; Detmar M
    Cancer Res; 2013 Feb; 73(3):1097-106. PubMed ID: 23243026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleaved endocan acts as a biologic competitor of endocan in the control of ICAM-1-dependent leukocyte diapedesis.
    Gaudet A; Portier L; Mathieu D; Hureau M; Tsicopoulos A; Lassalle P; De Freitas Caires N
    J Leukoc Biol; 2020 May; 107(5):833-841. PubMed ID: 32272492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocan - a potential diagnostic marker for early onset sepsis in neonates.
    Zonda GI; Zonda R; Cernomaz AT; Paduraru L; Avasiloaiei AL; Grigoriu BD
    J Infect Dev Ctries; 2019 Apr; 13(4):311-317. PubMed ID: 32045375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction.
    Ioakeimidou A; Pagalou E; Kontogiorgi M; Antoniadou E; Kaziani K; Psaroulis K; Giamarellos-Bourboulis EJ; Prekates A; Antonakos N; Lassale P; Gogos C;
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1749-1756. PubMed ID: 28455780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.